| Bioactivity | Omesdafexor is a FXR agonist. Omesdafexor can be used in the research of liver disease or a metabolic inflammation-mediated disease[1][2]. |
| Name | Omesdafexor |
| CAS | 2244440-85-3 |
| Formula | C34H43N3O3 |
| Molar Mass | 541.72 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf?sfvrsn=8544ca1e_3&download=true [2]. Song, Kenneth, et al. Farnesoid X receptor agonists for the treatment of a liver disease or a metabolic inflammation-mediated disease or disorder. Patent WO2020061114. |